Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Estimation of drug-metabolizing capacity by CYP-genotyping and CYP-expression

Published: Thursday, February 23, 2012
Last Updated: Thursday, February 23, 2012
Bookmark and Share
The lack of therapeutic effect of drugs or the appearance of undesired side-effects is partly caused by differences or changes in drug metabolism. This work aims to introduce an approach of combining CYP-genotyping and CYP-phenotyping tools to estimate patients’ drug-metabolizing capacity.

Abstract

Many undesired side-effects or therapeutic failures of drugs are the results of differences or changes in drug-metabolism, primarily depending on the levels and activities of cytochrome P450 (CYP) enzymes. In order to assess whether CYP-expression profiles can reflect the hepatic drug-metabolism, we compared CYP mRNA levels in the liver or in peripheral leukocytes with the corresponding hepatic CYP-activities. A preliminary CYP-genotyping for the most frequent polymorphisms in Caucasian populations (CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, CYP2D6*3, CYP2D6*4, CYP2D6*6 and CYP3A5*3) was carried out before CYP-phenotyping, excluding the donors with non-functional alleles of CYP2C9, CYP2C19 and CYP2D6, and those with functional CYP3A5*1 allele from a correlation analysis. The hepatic mRNA levels of CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 displayed a strong association with CYP-activities in the liver, whereas the expression of CYP1A2, CYP2C9, CYP2C19 and CYP3A4 in leukocytes was proven to reflect the hepatic activities of these CYP species. The leukocytes were found to be inappropriate cells for the assessment of hepatic CYP2B6 and CYP2D6 activities. Combining the results of CYP-genotyping and CYP-phenotyping analyses, patients' drug-metabolizing capacities can be estimated by the CYP-expression in the liver and also in leukocytes, with some limitations. Patients' genetic and non-genetic variations in CYP-status can guide the appropriate selection of drugs and the optimal dose, minimizing the risk of harmful side-effects and ensuring a successful outcome of drug therapy.

Thi sarticle is published online in The Journal of Pharmacology and Experimental Therapeutics and is free to view.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Proteomics for Systems Toxicology
MS-based proteomics is maturing into a robust technology for the measurement of proteome-wide exposure effects.
Monday, November 24, 2014
Persistent Pharmacokinetic Challenges to Pediatric Drug Development
Current knowledge of rational drug dose adjustments is limited, greater effort needs to be made to determine ontogenic factors that influence ADME.
Wednesday, October 08, 2014
ADME of Antibody-Maytansinoid Conjugates
Continued understanding of the ADME properties of ADCs entering clinical evaluations should provide additional insight into attributes that may be necessary for clinical success.
Wednesday, August 20, 2014
Epigenetic Regulation of ADME-Related Genes
The promise of epigenetic research is its potential to identify additional sources of inter individual variability in drug disposition and response.
Monday, August 04, 2014
Development and Validation of LC/MS/MS Method and its Application to a Pharmacokinetic Study
Researchers aimed to develop a LC/MS/MS method to monitor plasma levels of montelukast, gliclazide, and nifedipine for application in pharmacokinetic studies and routine clinical practice.
Monday, March 17, 2014
Gathering and Exploring Scientific Knowledge in Pharmacovigilance
The holistic assessment of widespread electronic medical records empowers valuable insights over adverse drug events.
Monday, February 24, 2014
Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance
Significant advances have been made in the development of plant-based hepatoprotective drugs mostly because of their lower toxicity.
Tuesday, December 03, 2013
Recent Advances in 2D and 3D in vitro Systems
The possibilities and limitations of the most useful liver in vitro systems are summarized, including 3D culture techniques, co-cultures with non-parenchymal cells.
Sunday, October 06, 2013
Epigenetic Regulation of ADME-Related Genes: Focus on Drug Metabolism and Transport
As research in epigenetic regulation of ADME genes progresses, there are many opportunities and challenges in understanding the epigenetic mechanisms in drug metabolism and disposition.
Monday, September 23, 2013
A Toxicokinetic Model for Thiamethoxam in Rats: Implications for Higher-Tier Risk Assessment
Toxicokinetic models are promising for wildlife risk assessments, but good understanding of feeding patterns is needed for accurate estimation of chronic risk.
Monday, June 17, 2013
Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
We present a case of a young female patient taking atomoxetine irregularly whose urine drug screen returned as a false-positive amphetamine result that was not confirmed.
Thursday, February 28, 2013
In-solution Hybrid Capture of Bisulfite-converted DNA for Targeted Bisulfite Sequencing of 174 ADME Genes
The aim of this study was to develop a method for the analysis of DNA methylation patterns in 174 ADME genes.
Monday, February 11, 2013
Alcohol ADME in Primates Studied with Positron Emission Tomography
This study aimed to use C-11 labeled alcohol, and C-11 and deuterium dual labeled alcohol, as a pair of PET tracers to study alcohol ADME in the baboon including its metabolism within the various organs.
Monday, January 28, 2013
Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction
Scientists have developed chimeric mice, in which mouse liver is replaced by transplanted human liver cells or tissue-engineered human liver.
Friday, November 16, 2012
Dendrimer Pharmacokinetics: The Effect of Size, Structure and Surface Characteristics on ADME Properties
This article explores the relationship between dendrimer structure and systemic disposition, and looks at the challenges of nonparental administration.
Thursday, October 04, 2012
Scientific News
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Novel Technique for Kidney Research Developed
To better understand how the treatment leads to kidney damage, and possibly prevent it, a team of researchers at Yale School of Medicine developed a new 3D-imaging technique to peer deep into these vital organs.
Microscopic Fish are 3D-Printed to do More Than Swim
Researchers demonstrate a novel method to build microscopic robots with complex shapes and functionalities.
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
A Better Way to Personalize Bladder Cancer Treatments
Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.
Breath of Fresh Air for Asthmatics
Researchers hope to develop a platform that will allow a range of drugs to be delivered by inhalation.
Capturing Cell Growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Elastic Patch Releases Drugs in a Stretch
Researchers from have developed a drug delivery technology that consists of an elastic patch that can be applied to the skin and will release drugs whenever the patch is stretched.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Liposomes: A Basis for Drugs of the Future
An international group of scientists have recently presented a review of liposomes, microscopic capsules widely used all over the world in the development of new drugs.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!